|

Incretin-Based Therapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Glucagon-like Peptide-1 Receptor Agonist

Pipeline

Phase 4: 1

Top Sponsors

  • Ali Aminian1

Indications

  • Metabolic Dysfunction-Associated Steatohepatitis (MASH)1
  • Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)1
  • Liver Disease1
  • Liver Fibrosis1
  • Non Alcoholic Fatty Liver Disease1

Phoenix, Arizona1 trial

Fibrosis Lessens After Metabolic Surgery

Banner Health Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.